Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-17 Purchase |
2024-12-18 08:27 am |
NRX Pharmaceuticals Inc. | NRXP | Javitt Jonathan C Chairman and Chief Scientist 10% Owner |
40,000 | $1.17 | $46,800 | 1,516,834 (Indirect Direct) |
View |
| 2023-08-23 Purchase |
2023-08-24 12:14 pm |
NRX Pharmaceuticals Inc. | NRXP | Javitt Jonathan C Chief Scientist 10% Owner |
100,000 | $0.33 | $33,000 | 14,768,329 (Indirect Direct) |
View |
| 2023-08-22 Purchase |
2023-08-23 09:24 am |
NRX Pharmaceuticals Inc. | NRXP | Javitt Jonathan C Chief Scientist 10% Owner |
200,000 | $0.322 | $64,400 | 14,668,329 (Indirect Direct) |
View |
| 2022-12-07 Sale |
2022-12-09 4:33 pm |
NRX Pharmaceuticals Inc. | NRXP | Javitt Jonathan C Director 10% Owner |
400,000 | $1 | $400,000 | 14,468,329 (Indirect Direct) |
View |
| 2022-06-01 Purchase(A) |
2022-06-02 09:46 am |
NRX Pharmaceuticals Inc. | NRXP | Javitt Jonathan C Chief Scientist 10% Owner |
100,000 | $0.58 | $58,000 | 14,868,329 (Indirect Direct) |
View |
| 2022-06-01 Purchase |
2022-06-02 08:55 am |
NRX Pharmaceuticals Inc. | NRXP | Javitt Jonathan C Chief Scientist 10% Owner |
100,000 | $58 | $5,800,000 | 14,868,329 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-12-14 Ownership |
2023-02-14 5:14 pm |
N/A N/A |
NRX Pharmaceuticals Inc. | NRXP | Javitt Jonathan C Director 10% Owner |
300,000 | $0 | 14,468,329 (Indirect) |
View |
| 2021-05-24 Option Award |
2021-06-10 6:48 pm |
N/A N/A |
NRX Pharmaceuticals Inc. | NRXP | Javitt Jonathan C Chief Executive Officer 10% Owner |
14,817,329 | $0 | 1,468,332 (Direct) |
View |